Beyaert, S., Loriot, A., Magremanne, M., Renwart, W., Mahy, P., Duprez, T., Baldin, P., Benidovskaya, E., Huyghe, N., Dahou, H., Stroobant, V., Gomard, T., Machiels, J.-P., & Schmitz, S. (2025). Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck. European Archives of Oto-Rhino-Laryngology: And Head & Neck, 282(11), 5841-5855. https://doi.org/10.1007/s00405-025-09655-8

BEYAERT, Simon, LORIOT, Axelle, MAGREMANNE, Michèle, RENWART, William, MAHY, Pierre, DUPREZ, Thierry, BALDIN, Pamela, BENIDOVSKAYA, Elena, HUYGHE, Nicolas, DAHOU, Hajar, STROOBANT, Vincent, GOMARD, Tiphanie, MACHIELS, Jean-Pascal und SCHMITZ, Sandra, 2025. Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck. European Archives of Oto-Rhino-Laryngology: and Head & Neck. 1 November 2025. Vol. 282, no. 11, p. 5841-5855. DOI 10.1007/s00405-025-09655-8.

Beyaert, S., A. Loriot, M. Magremanne, W. Renwart, P. Mahy, T. Duprez, P. Baldin, E. Benidovskaya, N. Huyghe, H. Dahou, V. Stroobant, T. Gomard, J.-P. Machiels, und S. Schmitz. „Translational Investigations in the HN1901 Phase II Window-of-Opportunity Study Investigating the Biological Activity of an IDO1 (IO102) and PD-L1 (IO103) Immune-Modulatory Peptide Cancer Vaccines in Squamous Cell Carcinoma of the Head and Neck“. European Archives of Oto-Rhino-Laryngology: And Head & Neck, Bd. 282, Nr. 11, November 2025, S. 5841-55, https://doi.org/10.1007/s00405-025-09655-8.

Beyaert, Simon/Loriot, Axelle/Magremanne, Michèle/Renwart, William/Mahy, Pierre/Duprez, Thierry u. a.: Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck, European Archives of Oto-Rhino-Laryngology: and Head & Neck 2025, 5841-5855.

Beyaert, S., Loriot, A., Magremanne, M., Renwart, W., Mahy, P., Duprez, T., Baldin, P., Benidovskaya, E., Huyghe, N., Dahou, H., Stroobant, V., Gomard, T., Machiels, J.-P. und Schmitz, S. (2025), „Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck“, European Archives of Oto-Rhino-Laryngology: And Head & Neck, Vol. 282 No. 11, S. 5841-5855.